News Focus
News Focus
Followers 21
Posts 941
Boards Moderated 0
Alias Born 12/16/2020

Re: exwannabe post# 806607

Saturday, 01/03/2026 1:23:19 PM

Saturday, January 03, 2026 1:23:19 PM

Post# of 818702
That is also assuming the 1st meeting was DCVax. The minutes say brain cancer in June 2024 and say Glioblastoma in November 2025. It could be a different drug. Vorasidneb was approved under project Orbis and likely submitted late 2023/early 2024. There's a good chance the June 2024 meeting was for Vorasidneb and not DCVax.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News